Company intelligence / Profile preview

Levicure

Rishon LeTsiyon, Central District, Israellevicure.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Levicure has developed a patented, orally administered triple-combination therapy for type 1 diabetes that combines two FDA-approved drugs—a DPP4 inhibitor and a proton pump inhibitor—with a proprietary extended-release formulation of GABA. Early proof-of-concept studies in animal models and a small patient cohort have shown potential for restoring endogenous insulin production, reducing or eliminating the need for exogenous insulin. The company is preparing to enter Phase 2a trials following encouraging pre-IND feedback from the FDA. No randomized controlled trial data are yet available.[1][2][4][6]

Therapeutic areas: Endocrinology
Modalities: Combination therapy (oral)Small moleculesExtended-release gastro-retentive formulation of GABA[1][2][3][6]
Industry: Biotech

Drug pipeline

1 asset

Triple therapy combination (GABA + DPP-4i + PPI)

Phase 2

Indications: Type 1 diabetes

Partnerships

StartUp Health Moonshot Fellowship Community member/partner[4]

Beyond the preview

Go deeper on Levicure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Levicure.

Explore the full profile